1. Home
  2. DCTH vs BLZE Comparison

DCTH vs BLZE Comparison

Compare DCTH & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • BLZE
  • Stock Information
  • Founded
  • DCTH 1988
  • BLZE 2007
  • Country
  • DCTH United States
  • BLZE United States
  • Employees
  • DCTH N/A
  • BLZE N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • BLZE Computer Software: Prepackaged Software
  • Sector
  • DCTH Health Care
  • BLZE Technology
  • Exchange
  • DCTH Nasdaq
  • BLZE Nasdaq
  • Market Cap
  • DCTH 630.4M
  • BLZE 326.5M
  • IPO Year
  • DCTH N/A
  • BLZE 2021
  • Fundamental
  • Price
  • DCTH $13.57
  • BLZE $5.36
  • Analyst Decision
  • DCTH Strong Buy
  • BLZE Strong Buy
  • Analyst Count
  • DCTH 4
  • BLZE 7
  • Target Price
  • DCTH $24.00
  • BLZE $10.29
  • AVG Volume (30 Days)
  • DCTH 734.6K
  • BLZE 387.0K
  • Earning Date
  • DCTH 08-04-2025
  • BLZE 08-07-2025
  • Dividend Yield
  • DCTH N/A
  • BLZE N/A
  • EPS Growth
  • DCTH N/A
  • BLZE N/A
  • EPS
  • DCTH N/A
  • BLZE N/A
  • Revenue
  • DCTH $53,850,000.00
  • BLZE $132,273,000.00
  • Revenue This Year
  • DCTH $155.42
  • BLZE $16.08
  • Revenue Next Year
  • DCTH $37.93
  • BLZE $13.97
  • P/E Ratio
  • DCTH N/A
  • BLZE N/A
  • Revenue Growth
  • DCTH 1068.87
  • BLZE 21.81
  • 52 Week Low
  • DCTH $7.17
  • BLZE $3.94
  • 52 Week High
  • DCTH $18.23
  • BLZE $8.08
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 38.26
  • BLZE 53.22
  • Support Level
  • DCTH $12.98
  • BLZE $5.29
  • Resistance Level
  • DCTH $14.18
  • BLZE $5.51
  • Average True Range (ATR)
  • DCTH 0.68
  • BLZE 0.20
  • MACD
  • DCTH -0.28
  • BLZE -0.01
  • Stochastic Oscillator
  • DCTH 15.95
  • BLZE 67.90

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.

Share on Social Networks: